Comparison of combination therapy of prednisolone and cyclosporine with corticosteroid pulse therapy in Vogt–Koyanagi

Comparison of combination therapy of prednisolone and cyclosporine with corticosteroid pulse therapy in Vogt–Koyanagi–Harada disease

Published:2021-10-24 Issue: Volume: Page:
ISSN:0021-5155
Container-title:Japanese Journal of Ophthalmology
language:en
Short-container-title:Jpn J Ophthalmol

Author:

Ono Takashi,Goto Hiroshi,Sakai Tsutomu,Nitta Fumihiko,Mizuki Nobuhisa,Takase Hiroshi,Kaneko Yutaka,Hori Junko,Nakano Satoko,Nao-I Nobuhisa,Ohguro Nobuyuki,Miyata Kazunori,Tomita Makoto,Mochizuki Manabu^ORCID,Mochizuki Manabu^ORCID,Ono Takashi,Komizo Takashi,Miyata Kazurori,Goto Hiroshi,Umazume Akihiko,Usui Yoshihiko,Sakai Tsutomu,Kohno Hideo,Aoyagi Ranko,Nitta Fumihiko,Maruyama Kazuichi,Mizuki Nobuhisa,Shibuya Etsuko,Ida Yasutsugu,Takase Hiroshi,Horie Shintaro,Ide Mitsunao,Iwasaki Yuko,Kamoi Koju,Terada Yukiko,Kaneko Yutaka,Hori Junko,Yui Tomoko,Takeda Ayaka,Nakano Satoko,Nao-I Nobuhisa,Ohguro Nobuyuki,Tomita Makoto,

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10384-021-00878-w.pdf

Reference39 articles.

1. Sugiura S. Some observations on uveitis in Japan, with special reference to Vogt–Koyanagi–Harada and Behcet diseases. Nippon Ganka Gakkai Zasshi. 1976;80:1285–326 ((In Japanese)).

2. Moorthy RS, Inomata H, Rao NA. Vogt–Koyanagi–Harada syndrome. Surv Ophthalmol. 1995;39:265–92.

3. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–52.

4. Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt–Koyanagi–Harada disease. J Immunol. 2000;165:7323–9.

5. Sugita S, Sagawa K, Mochizuki M, Shichijo S, Itoh K. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt–Koyanagi–Harada disease. Int Immunol. 1996;8:799–803.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Risk Stratification-Based Immunomodulatory Treatment Strategy for Vogt-Koyanagi-Harada Disease;American Journal of Ophthalmology;2024-06

2. Cost-Effectiveness Analysis of Adalimumab Versus Cyclosporine for Vogt-Koyanagi-Harada Disease: A Randomized Controlled Study;Current Eye Research;2024-05-23

3. Clinical and Transcriptional Profiles Reveal the Treatment Effect of Adalimumab in Patients with Initial-Onset and Recurrent Vogt–Koyanagi–Harada Disease;Ocular Immunology and Inflammation;2024-05-06

4. Incidence and Risk Factors of Recurrent Anterior Uveitis in Initial Acute-Onset Vogt-Koyanagi-Harada Disease;Korean Journal of Ophthalmology;2023-08-05

5. Immunosuppressive therapy for Vogt-Koyanagi-Harada disease: a retrospective study and review of literature;Journal of Ophthalmic Inflammation and Infection;2023-05-19